Evidence map›Paper›PMID 35114535›Full record

ReviewEuropean journal of radiology2022

Long-COVID diagnosis: From diagnostic to advanced AI-driven models.

Riccardo Cau, Gavino Faa, Valentina Nardi, Antonella Balestrieri, Josep Puig, Jasjit S Suri, Roberto SanFilippo, Luca Saba

Abstract readReview
In one paragraph

Review in European journal of radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Artificial Intelligence in Cardiovascular Health: Insights into Post-COVID Public Health Challenges.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2025
    Review
  5. Review
  6. Review
  7. Observational
  8. Article
  9. Machine learning predicts pulmonary Long Covid sequelae using clinical data.BMC medical informatics and decision making · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Health care for patients with long COVID: a scoping review.Revista da Escola de Enfermagem da U S P · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Riccardo CauDepartment of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari - Polo di Monserrato, s.s. 554 Monserrato, Cagliari 09045, Italy.
Gavino FaaDepartment of Pathology, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari, Italy.
Valentina NardiDepartment of Cardiovascular Medicine Mayo Clinic, Rochester, MN, USA.
Antonella BalestrieriDepartment of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari - Polo di Monserrato, s.s. 554 Monserrato, Cagliari 09045, Italy.
Josep PuigDepartment of Radiology (IDI), Hospital Universitari de Girona, Girona, Spain.
Jasjit S SuriStroke Diagnosis and Monitoring Division, Atheropoint LLC, Roseville, CA, USA.
Roberto SanFilippoDepartment of Vascular Surgery, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari - Polo di Monserrato, s.s. 554 Monserrato, Cagliari 09045, Italy.
Luca SabaDepartment of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), di Cagliari - Polo di Monserrato, s.s. 554 Monserrato, Cagliari 09045, Italy. Electronic address: lucasaba@tiscali.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-COV 2 is recognized to be responsible for a multi-organ syndrome. In most patients, symptoms are mild. However, in certain subjects, COVID-19 tends to progress more severely. Most of the patients infected with SARS-COV2 fully recovered within some weeks. In a considerable number of patients, like many other viral infections, various long-lasting symptoms have been described, now defined as "long COVID-19 syndrome". Given the high number of contagious over the world, it is necessary to understand and comprehend this emerging pathology to enable early diagnosis and improve patents outcomes. In this scenario, AI-based models can be applied in long-COVID-19 patients to assist clinicians and at the same time, to reduce the considerable impact on the care and rehabilitation unit. The purpose of this manuscript is to review different aspects of long-COVID-19 syndrome from clinical presentation to diagnosis, highlighting the considerable impact that AI can have.

Indexed as

COVID-19Artificial IntelligenceHumansPost-Acute COVID-19 SyndromeRNA, ViralSARS-CoV-2RNA, ViralAICOVID-19Long-COVIDSARS-COV2

Identifiers

PMID35114535
PMCPMC8791239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.